26th-Feb-2013 14:59Source: BSE

Ranbaxy Labs - Announces Q4 & FY12 results, Auditors Report & Results Press Release for the period ended December 31, 2012

Ranbaxy Laboratories Ltd has announced the following results for the quarter & year ended December 31, 2012:

The Audited results for the Quarter ended December 31, 2012

The Company has posted a net loss of Rs. (6160.96) million for the quarter ended December 31, 2012 as compared to net loss of Rs. (27103.21) million for the quarter ended December 31, 2011. Total Income has decreased from Rs. 39303.55 million for the quarter ended December 31, 2011 to Rs. 15086.32 million for the quarter ended December 31, 2012.

The Audited results for the Year ended December 31, 2012

The Company has posted a net loss of Rs.(1623.39) million for the Year ended December 31, 2012 as compared to net loss of Rs. (30520.49) million for the Year ended December 31, 2011. Total Income has decreased from Rs. 78251.98 million for the Year ended December 31, 2011 to Rs. 65431.42 million for the Year ended December 31, 2012.

The Consolidated Results are as follows:

The Audited results for the Quarter ended December 31, 2012

The Group has posted a net loss after tax, minority interest and share in loss of associate of Rs. (4924.48) million for the quarter ended December 31, 2012 as compared to net loss of Rs. (29827.69) million for the quarter ended December 31, 2011. Total Income has decreased from Rs. 38693.82 million for the quarter ended December 31, 2011 to Rs. 27878.87 million for the quarter ended December 31, 2012.

The Audited results for the Year ended December 31, 2012

The Group has posted a net profit after tax, minority interest and share in loss of associate of Rs. 9227.64 million for the Year ended December 31, 2012 as compared to net loss of Rs. (28997.29) million for the Year ended December 31, 2011. Total Income has increased from Rs. 103739.21 million for the Year ended December 31, 2011 to Rs. 127328.99 million for the Year ended December 31, 2012.